• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vir Biotechnology Inc (NQ: VIR )

    7.120 +0.170 (+2.45%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Vir Biotechnology Inc

    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday?
    Vir Biotechnology's Phase 2 study on hepatitis B treatments shows promising antigen loss rates, with up to 46% achieving seroclearance in key regimens. 
    Via Benzinga
    What You Missed On Wall Street This Past Friday
    Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 
    Via Talk Markets
    What's Next: Vir Biotechnology's Earnings Preview
    Via Benzinga
    Breaking Down Vir Biotechnology: 6 Analysts Share Their Views
    Via Benzinga
    VIR Stock Earnings: Vir Biotechnology Misses EPS, Misses Revenue for Q2 2024
    VIR stock results show that Vir Biotechnology missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Evaluating Vir Biotechnology: Insights From 5 Financial Analysts
    Via Benzinga
    Deep Dive Into Vir Biotechnology Stock: Analyst Perspectives (6 Ratings)
    Via Benzinga
    Assessing Vir Biotechnology: Insights From 5 Financial Analysts
    Via Benzinga
    Recap: Vir Biotechnology Q4 Earnings
    Via Benzinga
    Vir Biotechnology Stock Reaches 80-Plus RS Rating Benchmark
    On Friday, Vir Biotechnology stock had its Relative Strength (RS) Rating upgraded to 82, up from 64 a day earlier. 
    Via Investor's Business Daily
    3 Undervalued Biotech Gems With 200%+ Analyst Price Targets
    These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise. 
    Via InvestorPlace
    Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?
    Vir Biotechnology reports promising Phase 2 SOLSTICE hepatitis delta trial results, showing high virologic response and ALT normalization rates with tobevibart and elebsiran. 
    Via Benzinga
    Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Earnings Outlook For Vir Biotechnology
    Via Benzinga
    JP Morgan Downgrades Vir Biotechnology: Here's What You Need To Know
    Via Benzinga
    Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    VIR Stock Earnings: Vir Biotechnology Beats EPS for Q1 2024
    VIR stock results show that Vir Biotechnology beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
    These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations. 
    Via InvestorPlace
    Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
    One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses. 
    Via InvestorPlace
    3 Highly Rated Biotech Stocks to Buy for 300% Gains
    Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings. 
    Via InvestorPlace
    Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results. 
    Via Benzinga
    Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday
    U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
    Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation. 
    Via InvestorPlace
    HC Wainwright & Co. Maintains Buy Rating for Vir Biotechnology: Here's What You Need To Know
    Via Benzinga
    COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
    COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will close on 31 December 2023.&n 
    Via Benzinga
    Exposures COVID-19
    Earnings Scheduled For February 22, 2024
    Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million. 
    Via Benzinga
    7 Small-Cap Stocks to Buy BEFORE the Year-End Rally
    explore and wager on these top small-cap stocks to buy, poised for significant gains in today's dynamic global economy 
    Via InvestorPlace
    3 Bill Gates Stocks to Buy for Billionaire-Like Returns
    Microsoft and Berkshire Hathaway are the two most popular Bill Gates stocks. Investors know these three others far less. 
    Via InvestorPlace
    7 Biotech Stocks to Get In Now Before Investors Catch On
    Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them. 
    Via InvestorPlace
    Earnings Scheduled For November 2, 2023
    Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 10 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.